Showing 1091-1100 of 4943 results for "".
Content Curation: What to Know
https://practicaldermatology.com/topics/practice-management/content-curation-what-to-know/18761/Content curation can increase web exposure for medical practices. It's a tool for good SEO. In this Ekwa Educational video, you'll learn how to curate content effectively for optimal benefit.Neurotoxin Tips and Trends
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/neurotoxin-tips-and-trends/18743/The latest trends in aesthetic dermatology call for a more natural look. Dr. Rossi says dermatologists are injecting less units of neurotoxins, more strategically placed for a more cosmetically pleasing look. He stresses the need to think about neuromodulation rather than paralyzing the muscles to aRobert Grant Steps Down at Alphaeon; Skin Cancer Special Edition
https://practicaldermatology.com/topics/skin-cancer-photoprotection/dermwiretv-robert-grant-steps-down-at-alphaeon-skin-cancer-special-edition/18595/Robert Grant is no longer CEO of lifestyle healthcare company Alphaeon. Mr. Grant founded Alphaeon in 2013 as a wholly owned subsidiary of Strathspey Crown LLC, a private equity firm located in Newport Beach, CA, where he serves as Chairman. Also in this issue, a closer look at skin cancer. May is SEducating Patients with Psoriasis
https://practicaldermatology.com/topics/psoriasis/educating-patients-with-psoriasis/18781/Ronald Prussick, MD shares tips on talking to patients with psoriasis about their disease and associated risk factors. He discusses what patients need to understand about comorbidities and the life style changes they can make to improve their condition and overall health. He describes how he educateOnexton Approved for Acne, Bellafill Debuts
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-onexton-approved-for-acne-bellafill-debuts/19019/In this edition of DermWireTV, from the editors of Practical Dermatology® magazine: Onexton is Valeant's fourth new approval in a year. We look at Suneva's renamed filler and the FDA's decision to grant breakthrough status to investigational atopic dermatitis treatment dupilumab. PLUS: This week'sStarting a Practice? Get Educated
https://practicaldermatology.com/topics/practice-management/starting-a-practice-get-educated/19109/You know your medicine, but how well do you know business topics, like human resources, accounting, marketing, staffing, and other aspects of running a practice? Consider hiring a consultant, says Todd Schlesinger, MD, FAAD.Merz Acquires Ulthera; Ulthera Gets Decolletage Indication, and a New Topical for Onychomycosis
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-merz-acquires-ulthera-ulthera-gets-decolletage-indication-and-a-new-topical-for-onychomycosis/19117/In this edition of DermWireTV, from the publishers of Practical Dermatology® magazine, learn the latest on the Merz/Ulthera acquisition, a new topical for toenail fungus, and FDA accepts Kythera's NDA.PV-10: Update on an Emerging Melanoma Therapy
https://practicaldermatology.com/topics/skin-cancer-photoprotection/pv-10-update-on-an-emerging-melanoma-therapy/22971/Last year, Practical Dermatology reviewed data for an intralesional therapy for melanoma. Now a phase III trial appears imminent.Re-Considering the Psychological Components of Psoriasis
https://practicaldermatology.com/topics/psoriasis/re-considering-the-psychological-components-of-psoriasis/22962/With convincing data that show that psoriasis directly inhibits patients' daily activities and quality of life, clinicians must emphasize trust and empathy.Using Technology to Maintain a Personal Touch with Patients
https://practicaldermatology.com/topics/practice-management/using-technology-to-maintain-a-personal-touch-with-patients/21548/Patients do not want the convenience, efficiency, and lower costs achieved with better use of technology to compromise personal interactions with the doctor.